A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
VA Office of Research and Development
Fox Chase Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
NYU Langone Health
National Institutes of Health Clinical Center (CC)